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Background: A key factor underlying the control of the cellular growth, size and proliferation involves the
regulation of the total protein synthesis. Most often, the initial stages of mRNA translation are rate limiting, which
involves a group of eukaryotic translation initiation factors (EIFs). Research advances focused on the inhibition of
their expression and activity hold the key to the initiation and progression of tumor and tumor prognosis.
Method: We performed RNA interference (RNAi) with the lentivirus vector system to silence the EIF3B gene using
the colon cancer cell strain SW1116. The negative control included the normal target cells infected with the
negative control virus whereas the knockdown cells included the normal target cells transfected with the RNAi
target virus. We tested the inhibition resulting from the decreased expression of EIF3B gene on the proliferation rate
of SW1116 cells, including the cell cycle, apoptosis and clonability.
Results: Compared with the negative control, the impact of EIF3B gene expression in SW1116 cells on the levels of
mRNA and protein in the knockdown group, was significantly inhibited (P <0.01). Furthermore, the cell proliferation
rate and clonability were also significantly inhibited (P <0.01). The apoptosis rate increased significantly (P <0.05). A
significant decrease in the number of cells in the G1 phase (P <0.01) and significant increases in S (P <0.01) and G2
phases (P <0.05) were observed.
Conclusions: The silencing of EIF3B gene expression inhibits the proliferation of colon cancer cells.
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It is widely accepted that the uncontrolled proliferation
of tumor cells depends on increased protein synthesis
and ribosomal quantity [1,2]. Recent research suggests
that ribosomal protein synthesis plays a direct role dur-
ing the tumor initiation. A key factor underlying the
control of the cellular growth, size and proliferation
involves the regulation of the total protein synthesis.
Most often, the initial stages of mRNA translation are
rate limiting. The first step involves formation of an ini-
tiation complex of 43S pre-ribosome with subunits of
40s small ribosome, methionine tRNAi and a group of* Correspondence: wangzh1972@126.com
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reproduction in any medium, provided the oreukaryotic translation initiation factors (EIFs), such as
EIFs 1 and 2. The next step entails binding of the initi-
ation complex of 43S pre-ribosome with the 5′ end of
mRNA and then with the eukaryotic translation initi-
ation factor EIF4F. Other initiation factors that are
involved in the initial translation include: the multisubu-
nit EIF3; EIF5A, which is involved in protein and ribo-
some synthesis and stimulates the linkage of polypeptide
chain and extension of translation; active EIF6, which
codes for an insoluble protein and is found in the nu-
cleus and in the cytoplasm, functioning as a translation
initiation factor and preventing the association of the
40S and 60S ribosomal subunits. It binds to the fibro-
nectin type III domains of integrin, beta 4 (ITGB4) and
may help link ITGB4 to the intermediate filamenttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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play a critical role in protein synthesis, research advances
focused on the inhibition of their expression and activity
hold the key to the initiation and progression of tumor and
tumor prognosis.
This research was carried out by constructing a lenti-
viral vector containing RNA interference expression cas-
settes of EIF3B gene and introducing it into the colon
cancer cell strain SW1116 to analyze the effect of EIF3B
gene silencing on the proliferation of colon cancer cells.
Methods
Materials
The cell strain SW1116 of colon cancer was provided by
the Shanghai Institute of Digestive Disease. The dry
powder of RPMI-1640 cell culture fluid was purchased
from Gibco, Oklahoma USA. The restriction enzyme
was offered by New England Biolabs Inc., Ipswich, MA,
USA. The pGCSIL-GFP carrier was purchased from the
Shanghai Genechem Co., Ltd., Shanghai, China.
Reverse transcription polymerase chain reaction (RT-PCR)
analysis of EIF3B gene expression in tumor cells
The total RNA was extracted under RNase-free condi-
tions (carried out according to the operating manual of
Trizol from Invitrogen Corp., Carlsbad, CA) with
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
as an internal reference. Primer design was as follows.
\The EIF3B upstream sequence was: 5′-CGGTGCCTTA
GCGTTTGTG-3′; and the downstream sequence: 5′-
CGGTCCTTGTTGTTCTTCTGC-3′. The GAPDH up-
stream sequence was: 5′-TGACTTCAACAGCGACACC
CA-3′; its downstream sequence: 5′-CACCCTGTTGC
TGTAGCCAAA-3′. The Access RT-PCR kit was used to
perform single-step reverse transcription and PCR amplifi-
cation. An aliquot of 5 μl of amplified products was sub-
jected to electrophoresis on 2% agarose gel. The gels were
examined under the UV lamp.
Construct design: lentiviral-mediated small interfering
RNA delivery system
We targeted the gene of interest by designing small inter-
fering RNAs (siRNAs) using the design software developed
by Ambion Corp., Naugatuck, CT, USA to select the best
parameters for the RNA interference target. We deter-
mined the effective target sequence: PSC-1: GGGAGA
GAAATTCAAGCAAAT (EIF3B mRNA). We designed the
DNA oligonucleotides of siRNA (by Shanghai Genechem





CCC-3′.After annealing, the double-stranded DNA was
digested with AgeI and EcoRI to linearize the pGCSIL-
GFP vector. We modified the double-stranded DNA
after annealing and linked it with the pGCSIL-GFP vec-
tor following the double digestion. We used calcium
chloride to prepare competent cells of Escherichia coli
afresh and cultured it at 37°C for 16 hours. We used
computer-aided high-throughput cloning of bacteria in
liquid medium and sent it to the Shanghai Genechem
Co., Ltd for sequencing.
Preparation and grouping of cells
The SW1116 colon cancer cells were cultured in the
RPMI-1640 culture solution with fetal calf serum (vol-
ume fraction 10%) and incubated with 5% CO2 at 37°C.
The cells that remained in the logarithmic phase were
divided into two groups: negative control, in which the
normal target cells were infected with negative control
virus, and knockdown, in which the normal target cells
were infected with RNAi target virus.
Real-time PCR and western blot to test knockdown
efficiency
The SW1116 cells that grew well on the day prior to viral
introduction were recovered. The cell suspension was incu-
bated with 5% CO2 at 37°C. When the degree of cell fusion
reached 30%, adequate viral load was introduced in differ-
ent groups, to a multiplicity of infection (MOI) value of
100. Following incubation for three days, the expression
level of GFP was observed under the fluorescence micro-
scope. The culture was continued if the efficiency of infec-
tion exceeded 50%. After incubation for five days, the cells
were collected; the mRNA expression of the gene of interest
was analyzed using real-time PCR for RNA interference.
The upstream primer sequence for EIF3B gene was 5′-
GCCAAATAATCACCAACA-3′ while the downstream
primer sequence was 5′-CTGGTTCTGAGCAGGTTC-3′.
The cell culture solution was aspirated and the cells
washed twice in phosphate-buffered saline (PBS). Ad-
equate amount of pre-cooled 2 × lysis buffer was added.
After deplating, the cells were transferred to the tube
and then lysed on ice for 10 to 15 minutes. The protein
concentration was determined and adjusted to 2 μg/μl.
Next, 2 × loading buffer was added to each sample and
subsequently boiled for five to ten minutes. Forty micro-
grams of total protein was loaded into each well contain-
ing 10% SDS-polyacrylamide gel, subjected to electrophoresis
at 30 mA for two minutes, and then transferred to a polyviny-
lidene fluoride (PVDF) membrane at 400 mA for two hours.
The membrane was blocked with 5% milk in Tris-buffered sa-
line (TBS) for one hour at room temperature. The primary
antibody was added and incubated with the membrane for
two hours at room temperature, and then washed three times
with TBS/Tween 20. A secondary antibody was added to the
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agitation. Two hours later, the membrane was washed three
times with TBS/Tween 20 for 10 minutes per wash. The
bands were visualized using an enhanced chemiluminescence
(ECL) kit followed by exposure to X-ray film.
Cellomics to test inhibition of colon cancer proliferation
following downregulation of the EIF3B gene
After trypsinization, the cell suspension was resuspended in
complete medium and the density adjusted to 2×104/mL.
We used the blood counting chamber to count the cells,
laying them at 2000 cells/well. Each group comprised three
to five compound perforations. Each perforation was filled
with 100 μl, and same quantity of cells. The cells were incu-
bated with 5% CO2 and cultured at 37°C. Starting the next
day, the plates were tested and read once a day with Cello-
mics for five days. After adjusting the input parameters of
Cellomics ArrayScan (Thermo Fisher Scientific Inc, Wal-
tham, MA, USA), the quantity of cells with green fluores-
cence were accurately calculated while scanning the
perforations in the plates. The data were collected and ana-
lyzed to create a proliferation curve for the five days.
Fluorescence-activated cell sorting (FACS) to assess
inhibition of colon cancer cell cycle following EIF3B gene
silencing
The cell culture supernatant was aspirated when the cover-
age rate for 6 cm dish cells in experimental group increased
to 80%, ensuring that the cells did not enter the plateau
phase. The cells were washed once with the D-Hank’s solu-
tion and subjected to trypsinization. The complete medium
was removed and the cells were collected into a 5 ml centri-
fuge tube. We set three compound perforations in each
group and performed timed cycle tests ensuring adequate
number of cells for computerized analysis, with at least
1,000,000 each time. We used PBS (pH=7.2 to 7.4) that
was pre-cooled at 4°C to wash and precipitate cells once.
The cells were collected after centrifugation at 1500 rpm
for five minutes. The cells were fixed with 70% ethanol,
which was pre-cooled at 4°C, for at least one hour. The sta-
tionary liquid was abandoned by centrifugation at
1500 rpm for five minutes. We used the PBS to wash and
precipitate cells once. Adequate quantity of cell staining
fluid (1 to 1.5 ml) was added for resuspension, based on the
volume of cells, ensuring the pass rate of cells reached 200
to 350 cell/s for computer analysis. We used 300 mesh
screen cloth to filter within the tube while streaming onto
computer.
Fluorescence-activated cell sorting (FACS) analysis of
apoptosis inhibition following downregulation of the
EIF3B gene
We used D-Hank’s solution to wash cells once after col-
lecting the culture supernatant from each experimentalgroup following transfer into the 5 ml centrifuge tube.
We used pancreatic enzymes to digest the cells. The cul-
ture supernatants were then abandoned, and cells col-
lected into one 5ml centrifuge tube, with three
compound perforations in each group. The supernatants
were aspirated after centrifugation at 1500 rpm for five
minutes. We used PBS to wash and precipitate cells
once, then collected cells after centrifugation at
1500 rpm for five minutes. A 1 × binding buffer was then
used to wash and precipitate cells once, and centrifuge
at 1500 rpm for five minutes, The collected cells were
resuspended using 1 ml 1× staining buffer; the volume
of staining buffer solution was determined according to
the precipitation capacity of cells, adjusting the final
density of cell suspension to 1 × 106–1 × 107 cell/ml). We
took 100 μl cell suspension (1 × 105–1 × 106 cells) and
added 5 μl annexin V-APC for dyeing. The mixture was
placed in a dark place at room temperature for 10 to
15 min, and then transferred to the tube for streaming
onto computer for further analysis.
Inhibition of clonability of the cells following
downregulation of the EIF3B gene
We digested cells that remained in the logarithmic phase in
each experimental group, with pancreatic enzymes. The
cells were resuspended in complete medium. Using a blood
counting chamber, we inoculated the 96-well culture plate
at the rate of 500 cells per perforation in each experimental
group. We set three compound perforations in each experi-
mental group, transferred the cells that were already inocu-
lated into the incubator and they were cultured for three
days or when the number of cells in most single clones
exceeded five. During the process, the solution was changed
and cells monitored every three days. Using Cellomics
ArrayScan, we scanned and photographed the perforations,
analyzed the number and size of clones within the perfora-
tions and the number of cells in each clone.
Statistical methods
All data are presented as mean ± standard deviation
(x SD ). We used the statistical software SPSS12.0 to
perform the relevant analysis. The significance level of
statistics was set at P <0.05.
Results
Expression of EIF3B gene in SW1116 cells, preparation of
RNA-interfering lentivirus vector and test of knockdown
efficiency
The results of the semi-quantitative PCR, which set
GAPDH as an internal reference, showed that EIF3B
gene was abundantly expressed in colon cancer cell
SW1116 (Figure 1).
The length of PCR fragment in the positive clone that
anneals with the fragment of vshRNA was 343 base pair.
Figure 1 EIF3B mRNA expression in SW1116 cells.
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the GFP expression was observed under fluorescence
microscope (Figure 2). After five days, it was found that
the mRNA expression level of EIF3B gene in SW1116
cells of the knockdown group was inhibited, which was
significantly different compared with the negative con-
trol group (P <0.01). The western blot results suggested
inhibition of the protein level by the silenced EIF3B gene
in SW1116 cells. The RNA-interfering lentivirus of the
EIF3B gene construct effectively inhibited the expression
of EIF3B gene and several targets following the gene
silencing (Figure 3).
Cellomics analysis of inhibition of the proliferation of
colon cancer cells following downregulation of
EIF3B gene
After transfection with siRNA lentivirus, the prolifera-
tion volume of several SW1116 cells in the knockdownFigure 2 GFP expression in SW1116 cells under fluorescence microsco
(d) Scr-siRNA× 100.group was inhibited together with the negative control
from the third day (P <0.01). The results suggested that
downregulation of EIF3B gene inhibited the proliferation
of SW1116 cells (Figure 4).
FACS analysis of cell cycle inhibition due to EIF3B gene
silencing
Following transfection with siRNA lentivirus, the SW1116
cells in G1 phase decreased significantly (P <0.01), while
cells in S (P <0.01) and G2 phases increased significantly
(P <0.05) in the knockdown group compared with the
negative control group. It indicates that downregulation of
EIF3B gene was apparently related to regular distribution
of SW1116 cells (Figure 5).
FACS analysis of apotopsis inhibition following EIF3B
gene silencing
Transfection by siRNA lentivirus increased the volume
of apoptosis significantly (P <0.05) in the knockdown
group compared with the negative control group, sug-
gesting that EIF3B gene silencing stimulated apoptosis
of SW1116 cells (Figure 6) (Figure 7).
Analysis of inhibition of clonability due to EIF3B gene
silencing
We noticed a decrease in the volume of SW1116 cell
colonies in the knockdown group following interference
by siRNA lentivirus. Furthermore, the volume of cells inpe. (a) EIF3B-siRNA× 100. (b) EIF3B-siRNA× 200. (c) Scr-siRNA× 100.
Figure 3 EIF3B gene expression in SW1116 cells of the knockdown group. (a) In the knockdown group, the mRNA expression of EIF3B gene
in SW1116 cells decreases (**P <0.01 EIF3B-siRNA versus Scr-siRNA). (b) In the knockdown group, the protein expression of EIF3B gene in SW1116
cells decreases.
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was significantly different from the negative control
group (P <0.01). The results suggest that downregula-
tion of EIF3B gene largely inhibited the clonability of
SW1116 cells (Figure 8).Figure 4 Downregulation of EIF3B gene inhibits proliferation of SW11
group is inhibited together with the negative control group (**P <0.01 EIF
the knockdown group is inhibited together with the negative control grouDiscussion
Recent research on mRNA transcription and protein syn-
thesis in malignant tumor demonstrates the key role
played by translational control in the tumorigenesis path-
ways. The mechanisms may entail the general control of16 cells. (a) Proliferation volume of SW1116 cells in the knockdown
3B-siRNA versus Scr-siRNA). (b) Proliferation multiple of SW1116 cells in
p (**P <0.01 EIF3B-siRNA versus Scr-siRNA).
Figure 5 SW1116 cell cycle changes in the knockdown group. (**P <0.01 EIF3B-siRNA versus Scr-siRNA, *P <0.05 EIF3B-siRNA versus Scr-siRNA).
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mRNAs resulting in cancer cell survival, revascularization,
mutation, invasion and metastasis. A variety of transla-
tional control mechanisms exist in tumors, among which
the level of translational factors is critical. Since most
translational control of mRNA occurs at the initial stage,
it is extremely significant to understand the inhibition of
expression and variations in activity of translational
initiation factors and their impact on the growing tumor.
Eukaryotic initiation factors exist in several classes and
series of subunits each. The EIF2 includes α, β and γ
subunits. When the EIF2α undergoes phosphorylation, it
stops the recovery of GTP on EIF2α from EIF2β, thereby
stopping the protein synthesis. Research suggests thatFigure 6 Downregulation of EIF3B gene stimulates apoptosis of SW11mouse tumors were promoted by inhibiting the phos-
phorylation of EIF2α [3,4]. The EIF5A is a highly con-
served translational initiation factor, which is necessary
for cell proliferation. It occurs in two types in human
cells: EIF5A1, which is the expressive type; and EIF5A2,
which is the restricted type. The synthesis and increase
of protein and ribosome in the two EIF5As are asso-
ciated with the polypeptide chain linkages, but also are
important steps in translational extension [5]. In the
transplantation model of heterogeneous tumor within
mouse, the overexpression of EIF5A2 stimulated tumor
growth. The EIF6 is a multifunctional translational fac-
tor. Its main function is related to the creation of ribo-
some within nucleus [6]. Furthermore, it modified the16 cells (Peak diagram). (*P <0.05 EIF3B-siRNA versus Scr-siRNA).
Figure 7 Downregulation of EIF3B gene promotes apoptosis of SW1116 cells (Scatter diagram). (*P <0.05 EIF3B-siRNA versus Scr-siRNA).
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of EIF6 is probably related to its location within the cell.
Research suggests that decreasing the EIF6 level in cyto-
plasm inhibited the development of tumor while increas-
ing the level of nucleolus-stimulated tumor formation
[7]. The EIF4 is an important translational factor stimu-
lating the development of tumor. It includes: the EIF4E,
which is the cap-conjugated protein; the EIF4A, which is
an adenosine triphosphate (ATP)-dependent RNA heli-
case; RNA-conjugated protein, similar to EIF4B, EIF4G
and so on [8]. In the transgenic mouse model, theFigure 8 Compared with the negative control group, the clonability o
(*P <0.01 EIF3B-siRNA versus Scr-siRNA).overexpression of EIF4E caused B cell lymphoma, lung
cancer, liver cancer and angiosarcoma [9,10]. The EIF4A
is overexpressed in cell lines of melanoma, some primary
melanomas and primary hepatocellular carcinoma [11].
In some tumor-bearing animal models, depleting the
EIF4A from the EIF4F complex pharmacologically inhib-
ited the initial synthesis of protein and increased the
drug sensitivity of tumor. The EIF4G1 is overexpressed
in scaly lung cancer [12,13].
The mammalian EIF3 complex contains 10 to 13 pro-
teins. Its main function is to adjust the interactionf SW1116 cells in the knockdown group is significantly inhibited.
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of protein synthesis. The EIF3 complex is related to the
40S ribosome. It is also useful in the addition of EIF1,
EIF1A, EIF2, GTP, methionine tRNAi and EIF5 to the
43S ribosomal complex. The linkage of EIF3 complex
and EIF4F stimulates the mRNA addition to 43S riboso-
mal complex. In addition, the disassembly and recycling
of terminal ribosome also require EIF3. At the same
time, it prevents the early association between subunits
of 40S ribosome and 60S ribosome before translation
[14-16]. Because of its key role in the process of protein
synthesis, the EIF3 has a variety of functions in malig-
nant tumors. EIF3 consists of many subunits, which in-
clude EIF3a, EIF3B, EIF3c, EIF3i and so forth, each with
its own function. Several of these subunits form the core
complex, which is necessary for the protein synthesis,
while other subunits are useful in adjusting the function
of EIF3 complex or initiating the internal interactions
between EIF3 and special mRNA [17]. EIF3a is abun-
dantly expressed in many tumors within the human
body. Antisense RNA decreased its expression in vitro
and reversed the malignant phenotype. The overexpres-
sion of EIF3c caused many kinds of tumors within the
human body, via excessive protein translation. It may
help with protein synthesis, protein binding and restrict
the inhibitory factors of tumor. EIF3H usually is overex-
pressed in prostate cancer and breast cancer. In small
cell lung cancer, the overexpression of EIF3H indicates a
positive therapeutic response to Iressa therapy. The
EIF3F and EIF3E have characteristics similar to tumor
inhibitory factors, which inhibit the cell proliferation
and promote apoptosis. EIF3F lacks expression in mel-
anoma, unlike in benign pathological change of skin,
such as mole [18-20]. In breast cancer and lung cancer
within the human body, the expression of EIF3E
decreases [21-23]. EIF3B is an important part of the
EIF3 complex, involved in tumor formation. The overex-
pression of EIF3A, EIF3B, EIF3C and EIF3I subunits sti-
mulates the NIH3T3 cell total protein synthesis and
promotes the translational function of special RNAs
such as cycin D, Myc, ornithine decarboxylase (ODC)
and the growth factor of collagenous fiber alpha [24].
Conclusion
In our study, using the RNA interference with lentivirus
vector containing the EIF3B gene, we knocked down the
expression of EIF3B gene in the colon cancer cell strain
SW1116. After successful downregulation of EIF3B
mRNA and protein expression, the proliferation rate and
clonability of SW1116 cells were also inhibited signifi-
cantly. The apoptosis increased significantly while the
cell cycle was influenced. Downregulation of EIF3B gene
expression inhibited the proliferation of colon cancer
cells.Changes in protein synthesis and translational control
play a critical role in the complex mechanism underlying
tumor formation. They include changes in protein synthe-
sis and selective translational control of mRNA, tumor
vessel formation, inhibition of tumor cell apoptosis,
increased proliferation of tumor cells, and interaction be-
tween tumor cells and microenvironment. Research into
the underlying mechanisms may have implications for
therapeutic outcomes.
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